Purposeful

Executive Summary

Purposeful is a London-based digital health startup leveraging artificial intelligence to discover new treatments for rare diseases through drug repurposing. Founded in 2020, the company employs AI to analyze existing marketed drugs and match them to disease phenotypes, aiming to reverse disease progression. By focusing on repurposing, Purposeful reduces the time and cost associated with traditional drug development, while addressing the high unmet need in rare disease therapies. The company operates in the rapidly growing AI-driven drug discovery space, with a vision to expand its platform to common diseases in the future. Despite being at an early stage and lacking disclosed funding or revenue, Purposeful's approach aligns with industry trends toward computational drug development and precision medicine.

Upcoming Catalysts (preview)

• Q2 2027Strategic Partnership with Pharmaceutical Company60% success
• Q4 2026Proof-of-Concept Data from Preclinical Studies50% success
• Q3 2026Series A Funding Round65% success